 John Thompson
Concepts (265)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 30 | 2025 | 220 | 10.180 |
Why?
| | Parkinson Disease | 30 | 2025 | 601 | 8.690 |
Why?
| | Subthalamic Nucleus | 16 | 2025 | 84 | 7.780 |
Why?
| | Beta Rhythm | 3 | 2025 | 33 | 1.890 |
Why?
| | Drug Resistant Epilepsy | 5 | 2025 | 140 | 1.800 |
Why?
| | Epilepsy | 3 | 2025 | 390 | 1.320 |
Why?
| | Globus Pallidus | 3 | 2021 | 25 | 1.190 |
Why?
| | Putamen | 2 | 2020 | 23 | 1.160 |
Why?
| | Wakefulness | 4 | 2025 | 170 | 1.150 |
Why?
| | Sleep Stages | 4 | 2024 | 76 | 1.050 |
Why?
| | Basal Ganglia | 3 | 2023 | 57 | 1.010 |
Why?
| | Brain | 6 | 2025 | 2969 | 0.950 |
Why?
| | Brain Waves | 2 | 2017 | 45 | 0.900 |
Why?
| | Sodium Glutamate | 2 | 2016 | 12 | 0.890 |
Why?
| | Pedunculopontine Tegmental Nucleus | 2 | 2016 | 6 | 0.890 |
Why?
| | Pars Reticulata | 2 | 2022 | 8 | 0.890 |
Why?
| | Solitary Nucleus | 2 | 2016 | 25 | 0.880 |
Why?
| | Electrocorticography | 1 | 2025 | 20 | 0.870 |
Why?
| | Electrodes, Implanted | 7 | 2025 | 114 | 0.850 |
Why?
| | Anterior Thalamic Nuclei | 1 | 2024 | 5 | 0.850 |
Why?
| | Proto-Oncogene Proteins c-fos | 2 | 2016 | 196 | 0.840 |
Why?
| | Sleep | 4 | 2025 | 889 | 0.810 |
Why?
| | Seizures | 2 | 2025 | 485 | 0.790 |
Why?
| | Neurons | 9 | 2024 | 1652 | 0.750 |
Why?
| | Diffusion Tensor Imaging | 3 | 2021 | 78 | 0.750 |
Why?
| | Thalamus | 3 | 2021 | 129 | 0.750 |
Why?
| | Methylphenidate | 1 | 2022 | 49 | 0.700 |
Why?
| | Hallucinogens | 1 | 2023 | 111 | 0.650 |
Why?
| | Circadian Rhythm | 1 | 2025 | 513 | 0.640 |
Why?
| | Caudate Nucleus | 1 | 2020 | 22 | 0.640 |
Why?
| | Decision Making | 3 | 2018 | 982 | 0.620 |
Why?
| | Butylated Hydroxytoluene | 2 | 2011 | 37 | 0.610 |
Why?
| | Middle Aged | 27 | 2025 | 36302 | 0.600 |
Why?
| | Health Literacy | 1 | 2022 | 186 | 0.590 |
Why?
| | Microelectrodes | 4 | 2024 | 49 | 0.580 |
Why?
| | Intraoperative Awareness | 1 | 2018 | 4 | 0.550 |
Why?
| | Intraoperative Neurophysiological Monitoring | 2 | 2021 | 32 | 0.540 |
Why?
| | Male | 39 | 2025 | 73003 | 0.530 |
Why?
| | Taste Perception | 2 | 2016 | 31 | 0.530 |
Why?
| | Humans | 52 | 2025 | 145763 | 0.520 |
Why?
| | White Matter | 1 | 2019 | 155 | 0.520 |
Why?
| | Polysomnography | 5 | 2024 | 239 | 0.510 |
Why?
| | Aged | 20 | 2025 | 26215 | 0.510 |
Why?
| | Glioma | 2 | 2021 | 429 | 0.470 |
Why?
| | Space Perception | 1 | 2016 | 82 | 0.460 |
Why?
| | Cannabis | 1 | 2023 | 510 | 0.460 |
Why?
| | Essential Tremor | 3 | 2024 | 24 | 0.450 |
Why?
| | Dystonia | 3 | 2024 | 27 | 0.450 |
Why?
| | Female | 30 | 2025 | 79035 | 0.440 |
Why?
| | Choice Behavior | 1 | 2016 | 180 | 0.430 |
Why?
| | Lac Operon | 1 | 2014 | 44 | 0.430 |
Why?
| | beta-Galactosidase | 1 | 2014 | 76 | 0.420 |
Why?
| | Mental Recall | 1 | 2016 | 223 | 0.420 |
Why?
| | Movement Disorders | 1 | 2014 | 69 | 0.400 |
Why?
| | tau Proteins | 1 | 2014 | 105 | 0.390 |
Why?
| | Intralaminar Thalamic Nuclei | 2 | 2025 | 22 | 0.390 |
Why?
| | Neuroma, Acoustic | 2 | 2024 | 55 | 0.380 |
Why?
| | Dystonic Disorders | 2 | 2024 | 27 | 0.370 |
Why?
| | Laser Therapy | 3 | 2021 | 144 | 0.370 |
Why?
| | Models, Neurological | 1 | 2014 | 250 | 0.360 |
Why?
| | Tremor | 3 | 2023 | 98 | 0.360 |
Why?
| | Hypokinesia | 2 | 2022 | 11 | 0.340 |
Why?
| | Magnetic Resonance Imaging | 5 | 2024 | 3915 | 0.340 |
Why?
| | Xenobiotics | 1 | 2011 | 30 | 0.330 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2010 | 9 | 0.330 |
Why?
| | Vocalization, Animal | 1 | 2010 | 28 | 0.330 |
Why?
| | Finches | 1 | 2010 | 14 | 0.330 |
Why?
| | Oxidants | 1 | 2011 | 99 | 0.330 |
Why?
| | Brain Mapping | 2 | 2025 | 542 | 0.310 |
Why?
| | Endocannabinoids | 1 | 2010 | 56 | 0.310 |
Why?
| | Pilot Projects | 3 | 2025 | 1897 | 0.310 |
Why?
| | Glutamic Acid | 1 | 2010 | 255 | 0.280 |
Why?
| | Adult | 14 | 2025 | 40872 | 0.270 |
Why?
| | Alcohol Oxidoreductases | 1 | 2008 | 61 | 0.270 |
Why?
| | Neuronal Plasticity | 1 | 2010 | 305 | 0.270 |
Why?
| | Action Potentials | 3 | 2024 | 502 | 0.270 |
Why?
| | Carcinogens | 1 | 2008 | 123 | 0.260 |
Why?
| | Electroencephalography | 3 | 2025 | 563 | 0.260 |
Why?
| | Learning | 1 | 2010 | 444 | 0.240 |
Why?
| | Trapezoid Body | 2 | 2016 | 9 | 0.230 |
Why?
| | Implantable Neurostimulators | 1 | 2025 | 9 | 0.220 |
Why?
| | Young Adult | 6 | 2025 | 14251 | 0.220 |
Why?
| | Motor Activity | 3 | 2021 | 718 | 0.220 |
Why?
| | Superior Colliculi | 2 | 2015 | 44 | 0.220 |
Why?
| | Cavernous Sinus | 1 | 2024 | 16 | 0.210 |
Why?
| | Enzyme Inhibitors | 1 | 2008 | 821 | 0.210 |
Why?
| | Animals | 14 | 2022 | 38097 | 0.210 |
Why?
| | Antioxidants | 1 | 2008 | 550 | 0.210 |
Why?
| | Actigraphy | 1 | 2025 | 148 | 0.210 |
Why?
| | Pneumocephalus | 1 | 2024 | 5 | 0.210 |
Why?
| | Mice, Transgenic | 4 | 2016 | 2191 | 0.190 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2023 | 44 | 0.190 |
Why?
| | Ear, Inner | 1 | 2023 | 51 | 0.190 |
Why?
| | Taste | 2 | 2016 | 238 | 0.190 |
Why?
| | Reward | 2 | 2016 | 248 | 0.190 |
Why?
| | Treatment Outcome | 9 | 2024 | 11793 | 0.180 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5992 | 0.180 |
Why?
| | Proof of Concept Study | 1 | 2022 | 89 | 0.180 |
Why?
| | Observer Variation | 1 | 2023 | 357 | 0.180 |
Why?
| | Skull Base | 2 | 2020 | 55 | 0.170 |
Why?
| | Psychosurgery | 1 | 2021 | 9 | 0.170 |
Why?
| | Tertiary Care Centers | 1 | 2023 | 195 | 0.170 |
Why?
| | Substantia Nigra | 1 | 2022 | 64 | 0.170 |
Why?
| | Surgical Wound Infection | 1 | 2025 | 329 | 0.170 |
Why?
| | Cannabidiol | 1 | 2024 | 142 | 0.170 |
Why?
| | Zona Incerta | 1 | 2021 | 3 | 0.170 |
Why?
| | Upper Extremity | 1 | 2022 | 113 | 0.170 |
Why?
| | Craniotomy | 1 | 2021 | 84 | 0.170 |
Why?
| | Mice | 8 | 2021 | 18355 | 0.170 |
Why?
| | Consensus | 1 | 2023 | 479 | 0.170 |
Why?
| | Dronabinol | 1 | 2024 | 249 | 0.160 |
Why?
| | Neurosurgical Procedures | 2 | 2024 | 202 | 0.160 |
Why?
| | Retrospective Studies | 8 | 2025 | 17325 | 0.160 |
Why?
| | Anesthesia, General | 1 | 2021 | 121 | 0.160 |
Why?
| | Anticonvulsants | 1 | 2023 | 246 | 0.160 |
Why?
| | Atrophy | 1 | 2020 | 199 | 0.150 |
Why?
| | Biomechanical Phenomena | 1 | 2022 | 860 | 0.140 |
Why?
| | Evoked Potentials, Auditory | 1 | 2020 | 181 | 0.140 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 171 | 0.140 |
Why?
| | Neoplasm Grading | 1 | 2019 | 311 | 0.140 |
Why?
| | Robotic Surgical Procedures | 1 | 2021 | 185 | 0.140 |
Why?
| | Psychoacoustics | 1 | 2018 | 10 | 0.140 |
Why?
| | Intraoperative Period | 1 | 2018 | 69 | 0.140 |
Why?
| | Corpus Striatum | 1 | 2020 | 179 | 0.140 |
Why?
| | Behavior, Animal | 1 | 2021 | 520 | 0.130 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3416 | 0.130 |
Why?
| | Lung | 1 | 2011 | 4116 | 0.130 |
Why?
| | Psychotic Disorders | 1 | 2020 | 192 | 0.130 |
Why?
| | Neuropsychological Tests | 1 | 2022 | 1137 | 0.130 |
Why?
| | Algorithms | 1 | 2025 | 1850 | 0.120 |
Why?
| | Orientation | 2 | 2015 | 50 | 0.120 |
Why?
| | Mice, Inbred BALB C | 2 | 2011 | 1261 | 0.120 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2017 | 38 | 0.120 |
Why?
| | REM Sleep Behavior Disorder | 1 | 2016 | 17 | 0.120 |
Why?
| | Acoustic Stimulation | 1 | 2018 | 333 | 0.120 |
Why?
| | Grape Seed Extract | 2 | 2013 | 29 | 0.120 |
Why?
| | Biomarkers | 2 | 2025 | 4302 | 0.120 |
Why?
| | Stereotaxic Techniques | 1 | 2016 | 42 | 0.120 |
Why?
| | Brain Injuries | 1 | 2021 | 507 | 0.120 |
Why?
| | Cadaver | 3 | 2024 | 311 | 0.120 |
Why?
| | Drinking | 1 | 2016 | 44 | 0.120 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 583 | 0.110 |
Why?
| | Odorants | 1 | 2016 | 114 | 0.110 |
Why?
| | Cues | 1 | 2018 | 329 | 0.110 |
Why?
| | Referral and Consultation | 1 | 2022 | 868 | 0.110 |
Why?
| | Amygdala | 1 | 2017 | 200 | 0.110 |
Why?
| | Neoplasm Staging | 1 | 2019 | 1474 | 0.110 |
Why?
| | Vision Disorders | 1 | 2017 | 179 | 0.110 |
Why?
| | Postoperative Complications | 2 | 2025 | 2977 | 0.110 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2019 | 782 | 0.110 |
Why?
| | Stimulation, Chemical | 1 | 2014 | 52 | 0.110 |
Why?
| | Dyskinesias | 1 | 2014 | 20 | 0.110 |
Why?
| | Acetylcholine | 1 | 2015 | 209 | 0.110 |
Why?
| | Anxiety | 1 | 2022 | 1122 | 0.100 |
Why?
| | Synapses | 2 | 2016 | 439 | 0.100 |
Why?
| | Staining and Labeling | 1 | 2014 | 153 | 0.100 |
Why?
| | Optogenetics | 1 | 2015 | 103 | 0.100 |
Why?
| | Psychometrics | 1 | 2018 | 731 | 0.100 |
Why?
| | Membrane Potentials | 1 | 2014 | 278 | 0.100 |
Why?
| | Anthocyanins | 1 | 2013 | 28 | 0.100 |
Why?
| | Schizophrenia | 1 | 2017 | 464 | 0.100 |
Why?
| | Cytokines | 1 | 2021 | 2069 | 0.100 |
Why?
| | Symptom Assessment | 1 | 2014 | 136 | 0.100 |
Why?
| | Neural Inhibition | 1 | 2014 | 178 | 0.100 |
Why?
| | Locomotion | 1 | 2013 | 101 | 0.090 |
Why?
| | Equipment Design | 1 | 2014 | 525 | 0.090 |
Why?
| | Smell | 1 | 2013 | 126 | 0.090 |
Why?
| | Receptors, Androgen | 1 | 2013 | 149 | 0.090 |
Why?
| | Task Performance and Analysis | 1 | 2013 | 198 | 0.090 |
Why?
| | Stroke | 1 | 2021 | 1271 | 0.090 |
Why?
| | Proanthocyanidins | 1 | 2011 | 6 | 0.090 |
Why?
| | Biflavonoids | 1 | 2011 | 6 | 0.090 |
Why?
| | STAT3 Transcription Factor | 1 | 2013 | 206 | 0.090 |
Why?
| | Glucuronides | 1 | 2011 | 18 | 0.090 |
Why?
| | Microsomes, Liver | 1 | 2011 | 85 | 0.090 |
Why?
| | Catechin | 1 | 2011 | 23 | 0.090 |
Why?
| | Reactive Nitrogen Species | 1 | 2011 | 16 | 0.080 |
Why?
| | Hippocampus | 1 | 2017 | 973 | 0.080 |
Why?
| | Nerve Net | 1 | 2014 | 286 | 0.080 |
Why?
| | Glutathione Transferase | 1 | 2011 | 92 | 0.080 |
Why?
| | Adolescent | 3 | 2025 | 22573 | 0.080 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2011 | 178 | 0.080 |
Why?
| | Dendritic Spines | 1 | 2010 | 70 | 0.080 |
Why?
| | Endoscopy | 2 | 2024 | 317 | 0.080 |
Why?
| | NF-kappa B | 1 | 2013 | 667 | 0.080 |
Why?
| | Glutathione | 1 | 2011 | 370 | 0.070 |
Why?
| | Time Factors | 1 | 2020 | 7133 | 0.070 |
Why?
| | Alkylation | 1 | 2008 | 27 | 0.070 |
Why?
| | Synaptic Transmission | 1 | 2010 | 292 | 0.070 |
Why?
| | Reactive Oxygen Species | 1 | 2011 | 611 | 0.070 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 174 | 0.070 |
Why?
| | Cytosol | 1 | 2008 | 213 | 0.070 |
Why?
| | Lung Neoplasms | 2 | 2011 | 2667 | 0.060 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2008 | 592 | 0.060 |
Why?
| | Neural Pathways | 2 | 2020 | 317 | 0.060 |
Why?
| | Diphosphonates | 1 | 2006 | 68 | 0.060 |
Why?
| | Apoptosis | 1 | 2013 | 2443 | 0.050 |
Why?
| | Recombinant Proteins | 1 | 2008 | 1368 | 0.050 |
Why?
| | Sella Turcica | 1 | 2024 | 17 | 0.050 |
Why?
| | Neuroendoscopy | 1 | 2024 | 24 | 0.050 |
Why?
| | Patch-Clamp Techniques | 2 | 2016 | 289 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2021 | 4568 | 0.050 |
Why?
| | Facial Nerve | 1 | 2024 | 39 | 0.050 |
Why?
| | Biomarkers, Tumor | 1 | 2011 | 1329 | 0.050 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2024 | 156 | 0.050 |
Why?
| | Edema | 1 | 2023 | 125 | 0.050 |
Why?
| | Adrenergic Agents | 1 | 2021 | 7 | 0.040 |
Why?
| | Oxidopamine | 1 | 2021 | 14 | 0.040 |
Why?
| | Parkinson Disease, Secondary | 1 | 2021 | 8 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1723 | 0.040 |
Why?
| | Evoked Potentials, Motor | 1 | 2021 | 52 | 0.040 |
Why?
| | Mitochondria | 1 | 2008 | 992 | 0.040 |
Why?
| | Corpus Callosum | 1 | 2021 | 72 | 0.040 |
Why?
| | Electric Impedance | 1 | 2020 | 108 | 0.040 |
Why?
| | Sleep Wake Disorders | 1 | 2024 | 314 | 0.040 |
Why?
| | Nose | 1 | 2020 | 67 | 0.040 |
Why?
| | Fingers | 1 | 2020 | 107 | 0.040 |
Why?
| | Melanoma | 1 | 2006 | 761 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 2064 | 0.040 |
Why?
| | Movement | 1 | 2020 | 293 | 0.030 |
Why?
| | Meningioma | 1 | 2018 | 88 | 0.030 |
Why?
| | Meningeal Neoplasms | 1 | 2018 | 95 | 0.030 |
Why?
| | Dreams | 1 | 2016 | 14 | 0.030 |
Why?
| | Visual Pathways | 1 | 2017 | 61 | 0.030 |
Why?
| | Synaptosomal-Associated Protein 25 | 1 | 2016 | 25 | 0.030 |
Why?
| | Surgery, Computer-Assisted | 1 | 2017 | 85 | 0.030 |
Why?
| | Visual Fields | 1 | 2017 | 116 | 0.030 |
Why?
| | Gerbillinae | 1 | 2016 | 72 | 0.030 |
Why?
| | Spatial Behavior | 1 | 2015 | 24 | 0.030 |
Why?
| | Spinal Cord | 1 | 2018 | 382 | 0.030 |
Why?
| | Exploratory Behavior | 1 | 2015 | 85 | 0.030 |
Why?
| | Microscopy, Fluorescence | 1 | 2016 | 408 | 0.030 |
Why?
| | Fluorescence | 1 | 2015 | 159 | 0.030 |
Why?
| | Glycine Plasma Membrane Transport Proteins | 1 | 2014 | 5 | 0.030 |
Why?
| | Cholera Toxin | 1 | 2014 | 29 | 0.030 |
Why?
| | Rhodamines | 1 | 2014 | 19 | 0.030 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2014 | 44 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2006 | 2219 | 0.030 |
Why?
| | Electroporation | 1 | 2014 | 43 | 0.030 |
Why?
| | Photic Stimulation | 1 | 2015 | 264 | 0.030 |
Why?
| | Lysine | 1 | 2016 | 305 | 0.030 |
Why?
| | Glutamate Decarboxylase | 1 | 2014 | 165 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3634 | 0.020 |
Why?
| | Electric Stimulation | 1 | 2014 | 277 | 0.020 |
Why?
| | Functional Laterality | 1 | 2014 | 240 | 0.020 |
Why?
| | Single-Cell Analysis | 1 | 2016 | 361 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2014 | 407 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2014 | 1049 | 0.020 |
Why?
| | Prognosis | 1 | 2021 | 4329 | 0.020 |
Why?
| | Brain Neoplasms | 1 | 2021 | 1331 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2014 | 896 | 0.020 |
Why?
| | Dimerization | 1 | 2011 | 189 | 0.020 |
Why?
| | Methylation | 1 | 2011 | 242 | 0.020 |
Why?
| | Risk Factors | 1 | 2025 | 10917 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1103 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 3210 | 0.020 |
Why?
| | Palliative Care | 1 | 2017 | 1022 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2016 | 2933 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 8075 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5428 | 0.020 |
Why?
| | Age Factors | 1 | 2014 | 3346 | 0.020 |
Why?
| | Prostatic Neoplasms | 1 | 2013 | 981 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2013 | 2514 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 3551 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2006 | 8346 | 0.010 |
Why?
|
|
Thompson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|